Thylacine Bio engages in developing a peptide platform for pandemic preparedness.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Miami Beach
State: Florida
Zip:
Country: United States
Thylacine Bio engages in developing a peptide platform for pandemic preparedness. The platform can be rapidly tuned and applied to new and existing pathogens. It targets conserved regions less susceptible to mutation, unlocking efficacy across variants. The resulting antivirals are potent, self-administered, and easily distributed.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2023 | Seed Round | $476k | 1/2023 | Debt Financing | - | 1/2023 | Debt Financing | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|